Two higher-end models of the Apple Watch can go on sale again after a federal court temporarily lifted a sales halt ordered by the International Trade Commission over a patent dispute. The ITC, a federal agency, ordered the halt in October to block Apple from using specific technologies underpinning a blood-oxygen measurement system in its Series 9 and Ultra 2 watches. Apple has been embroiled in an intellectual property dispute with the medical technology company Masimo over those technologies. Apple cut off online sales of the watches in the US last week just days from the Christmas holiday to comply with the ITC ruling. The court's action will allow sales of the two Apple Watch models pending its decision on whether to also permit sales as it weighs Apple's appeal. The two watch models will be available at Apple's online store by noon Pacific Time on Thursday, according to the company. They will return to some Apple stores Wednesday, with wider availability expected by ...
Masimo's goal, people close to the matter say, was for the ITC to impose its ban in the summer
The U.S. International Trade Commission's (ITC) order will go into effect on Dec. 26, barring imports and sales of Apple Watches that use patent-infringing technology for reading blood-oxygen levels
Apple has been rebuffed in its latest attempt to untangle a patent dispute that is pushing the company into suspending sales of two popular Apple Watch models as the holiday shopping season wraps up. The International Trade Commission rejected Apple's bid to get around a late October order revolving around the technology used in the Blood Oxygen measurement feature on the Series 9 and Ultra 2 versions of its internet-connected watch. The dispute stems from a patent infringement claim filed in 2021 by medical technology company Masimo, culminating in a US ban on Apple using the technology that makes the Blood Oxygen feature work on those two watches The decision issued Wednesday means Apple will follow through on its plan to stop selling two watch models in the US to comply with the ITC ruling unless the Biden administration overturns it by Christmas. Online sales of the Apple Watch Series 9 and Ultra 2 are scheduled to stop at 3 pm EST Thursday and the devices will be pulled from .
The International Trade Commission ruled earlier this year that the Apple Watch violates two Masimo patents related to blood-oxygen sensing
If two of the latest Apple Watches are on your holiday shopping list, don't dawdle for much longer because the devices won't be available to buy in the US later this week if the White House doesn't intervene in an international patent dispute. Apple plans to suspend sales of the Series 9 and Ultra 2 versions of its popular watch for online US customers beginning on Thursday afternoon and in its stores on Sunday. The move stems from an October decision by the International Trade Commission restricting Apple's watches with the Blood Oxygen measurement feature as part of an intellectual property dispute with medical technology company Masimo. The White House had 60 days to review the ITC order issued on October 26, meaning Apple could have kept selling the two affected models in the US through Christmas. But the Cupertino, California, company said in a Monday statement that it is pausing sales early to ensure it complies with the ITC order. If the ITC's sales ban isn't overturned, Appl
Apple could settle with Masimo, though that's a route it typically prefers not to take. And the two companies don't appear to have engaged on that front
Sales of the Apple Watch Series 9 and Ultra 2 will be halted on the company's online store on Dec. 21 and at its physical retail stores beginning on Christmas Eve, it said in a statement
Earlier, tier-1 cities accounted for 65-70% of Apple's sales, however, this has changed in the last few years
No major changes are expected in the iPhone line, which is touted to retain current generation design. However, the Apple Watch and AirPods are likely to get new hardware and software upgrades
Tang Tan, whose title is vice president of product design, is leaving in February, according to people with knowledge of the matter
Apple will continue the trend of building custom technology to reduce dependency on component suppliers for future iPhones, Apple Watches and other products.
Apple is reportedly also working on non-invasive blood glucose monitoring technology, which is unlikely to debut with the Watch Series 10 in 2024
watchOS 10.1 is available for Watch Series 4 or later. It brings double tap gesture control, announced in September, to Watch Series 9 and Watch Ultra 2
Apple is offering up to Rs 10,000 instant savings, trade-in deals, and no-interest EMI on select products on its online store and retail outlets in Mumbai and Delhi
While the Apple Watch Series 9 may not initially appear as a significant upgrade, it holds promise with features such as the double-tap gesture and on-device Siri soon to be available
The devices are going on sale in about 40 countries in its first wave, including in Australia, Hong Kong, mainland China, the US, UK and France
The group working on the glucose tracker resides within Apple's semiconductor organization because the system relies on an advanced chip-based system
Announced earlier this year at Apple WWDC, the platform updates are set to arrive with new features and capabilities. Below are the details
According to a report by US-based tech portal TechCrunch, the Ultra 2's design looks quite similar to that of the first-generation Apple Watch Ultra, which means the most significant upgrade is on the